A radiohybrid theranostics ligand labeled with fluorine-18 and lutetium-177 for fibroblast activation protein-targeted imaging and radionuclide therapy.

Authors:
Yang T; Peng L; Qiu J; He X; Zhang D and 4 more

Journal:
Eur J Nucl Med Mol Imaging

Publication Year: 2023

DOI:
10.1007/s00259-023-06169-5

PMCID:
PMC10250256

PMID:
36864362

Journal Information

Full Title: Eur J Nucl Med Mol Imaging

Abbreviation: Eur J Nucl Med Mol Imaging

Country: Unknown

Publisher: Unknown

Language: N/A

Publication Details

Subject Category: Nuclear Medicine

Available in Europe PMC: Yes

Available in PMC: Yes

PDF Available: No

Transparency Score
3/6
50.0% Transparent
Transparency Indicators
Click on green indicators to view evidence text
Core Indicators
Data Sharing
Code Sharing
Evidence found in paper:

"Declarations Ethics approvalAll animal care and experimental procedure were performed following the guidelines of the care and use of laboratory animals approved by the First Affiliated Hospital of Sun Yat-Sen University Institutional Animal Care and Use Committee. Competing interestsThe authors declare no competing interests. Competing interests The authors declare no competing interests."

Evidence found in paper:

"Funding This work was supported by the Natural Science Foundation of Guangdong Province (2022A1515011670) and Key Research and Development Program of Guangzhou City (202206010046)."

Protocol Registration
Open Access
Paper is freely available to read
Additional Indicators
Replication
Novelty Statement
Assessment Info

Tool: rtransparent

OST Version: N/A

Last Updated: Aug 05, 2025